Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A randomised, multicentre, multinational Phase II study to evaluate pertuzumab in combination with trastuzumab given either concomitantly or sequentially with standard anthracycline based chemotherapy or concomitantly with a non-anthracycline based chemotherapy regimen, as neoadjuvant therapy for patients with locally advanced, inflammatory or early stage HER2-positive breast cancer https://kusajili.fr:443/Trial/IfMQkYBat0yA_12SMQDmjA%24a-randomised-multicentre-multinational-phase-ii-study-to-evaluate-pertuzumab-in-combination-with-trastuzumab-given-either-conco
I have read and accept the terms of use of the site and the Privacy Policy
Send your message